NextCure (NXTC) Stock: Buy, Sell, or Hold?
NXTC - NextCure, Inc. Common Stock
$5.05
-0.04 (-0.79%)
▼
5d:
-0.59%
30d:
-35.59%
90d:
+183.71%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
29d
Get Alerted When NXTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NXTC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NXTC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NXTC is currently trading at $5.05, which is considered oversold relative to its 30-day fair value range of $5.05 to $7.23.
Technical Outlook: Technically, NXTC is showing sideways momentum. Immediate support is located at $4.64, while resistance sits at $6.30.
Market Sentiment: NXTC scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $20.00 (+292.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NXTC is showing sideways momentum. Immediate support is located at $4.64, while resistance sits at $6.30.
Market Sentiment: NXTC scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $20.00 (+292.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.05 -
$7.23
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 292.9% below Wall St target ($20.00)
- CAUTION: Bottoming setup, but lagging the sector by 50% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$5.05 -
$7.23
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.64
Resistance Level
$6.30
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.86
Wall Street Target
$20.00
(+292.9%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: October 05, 2026 9:29 AM ET
Data refreshes hourly during market hours. Next update: 10:29 AM
Data refreshes hourly during market hours. Next update: 10:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NXTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 65 BUY |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 68 BUY |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
19 analysts |
$18 | 52 HOLD |
|
ZYME
Zymeworks Inc. Common St… |
STRONG BUY
14 analysts |
$41 | 60 BUY |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
14 analysts |
$107 | 67 BUY |
